Drawing for AUTEM MEDICAL

USPTO serial 97062262

AUTEM MEDICAL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GLUECK, CHRISTOPHER N
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AUTEM MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael A. Geller

Michael A. Geller DLA Piper LLP (US)P.O. Box 64807Chicago, IL 60664-0807UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Medical and dental devices, apparatus and instruments for monitoring and recording physiological functions, namely, cardiac electrical activity for medical and dental purposes; Medical devices, apparatus and instruments, namely, a device that emits radiofrequencies and measures and records cardiac electrical activity; Medical and dental devices, namely, radiofrequency generators for use in medical and dental treatment of cancer, cardiovascular disease, obstructive lung, pleural disease, renal insufficiency, viral, parasitical or other pathogenic invasions, diabetes, osteoporosis, dementia, incontinence, overactive bladder, prostate disease, organ dysfunctions, drug abuse, poisons, high low-density lipoprotein (LDL) cholesterol levels, and venom from a snake-bite; Medical and dental devices, apparatus and instruments for detecting and monitoring hemodynamic parameters such as heart rate variability, RR intervals (RRI), and other cardiac electrical activity for medical and dental purposes; Medical devices, apparatus and instruments, namely, a device for detecting and treating cancer, cardiovascular disease, obstructive lung, pleural disease, renal insufficiency, viral, parasitical or other pathogenic invasions, diabetes, osteoporosis, dementia, incontinence, overactive bladder, prostate disease, organ dysfunctions, drug abuse, poisons, high low-density lipoprotein (LDL) cholesterol levels, and venom from a snake-bite; Medical devices, apparatus and instruments for use in treating and diagnosing cancer, cardiovascular disease, obstructive lung, pleural disease, renal insufficiency, viral, parasitical or other pathogenic invasions, diabetes, osteoporosis, dementia, incontinence, overactive bladder, prostate disease, organ dysfunctions, drug abuse, poisons, high low-density lipoprotein (LDL) cholesterol levels, and venom from a snake-biteACTIVE—
044medical servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 18, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 18, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 13, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 13, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 13, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 13, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 13, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 16, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 21, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 21, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 14, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 9, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Feb 9, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 9, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 9, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 14, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 13, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 13, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 13, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2022DOCKASSIGNED TO EXAMINER—
Nov 2, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 30, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 9, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance